Concepedia

Author

Kevin Sheng‐Po Yuan

Taipei Medical University

Also Known As

Kevin Sheng-Po Yuan, Kevin Sheng‐Po Yuan, Kevin Yuan

24

Publications

789

Citations

14

H-Index

12

Concepts

All Affiliations

Taipei Medical UniversityWan Fang HospitalTaipei Medical University-Shuang Ho HospitalNational Taiwan UniversityLuodong Poh-Ai Hospital
KS

About

Kevin Sheng‐Po Yuan is an author at Taipei Medical University specializing in radiation oncology, medicine, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

225

2

Health Sciences

3

3

164

3

Radiation Medicine

1

1

40

4

Surgical Oncology

1

1

21

5

Cancer Therapeutics

1

1

28

Kevin Sheng‐Po Yuan

×

16

Publications

762

Citations

14

H-Index

YearCitations

Locoregionally recurrent head and neck squamous cell carcinoma: incidence, survival, prognostic factors, and treatment outcomes

Jer‐Hwa Chang, Chia‐Che Wu, Kevin Sheng‐Po Yuan,

Oncotarget

2017

203

Dose escalation intensity-modulated radiotherapy–based concurrent chemoradiotherapy is effective for advanced-stage thoracic esophageal squamous cell carcinoma

Chia-Lun Chang, Hsieh‐Chih Tsai, Wei-Cheng Lin,

Radiotherapy and Oncology

2017

103

Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity‐modulated radiation therapy techniques

Yu‐Chun Yen, Jer‐Hwa Chang, Wei‐Cheng Lin,

Cancer

2017

68

Safety and Validity of Mechanical Thrombectomy and Thrombolysis on Severe Cerebral Venous Sinus Thrombosis

Guangwen Li, Xianwei Zeng, Mohammed Hussain,

Neurosurgery

2013

66

Assessment of Predictive Scoring System for 90-Day Mortality Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Completed Concurrent Chemoradiotherapy

Kuan‐Chou Lin, Tsung-Ming Chen, Kevin Sheng‐Po Yuan,

JAMA Network Open

2020

49

Efficacy of thoracic radiotherapy in patients with stage IIIB–IV epidermal growth factor receptor-mutant lung adenocarcinomas who received and responded to tyrosine kinase inhibitor treatment

Yu‐Chun Yen, Han-Lin Hsu, Jer‐Hwa Chang,

Radiotherapy and Oncology

2018

40

High‐dose or low‐dose cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer

Chia‐Lun Chang, Kevin Sheng‐Po Yuan, Szu‐Yuan Wu

Head & Neck

2017

37

Treatment of advanced nasopharyngeal cancer using low- or high-dose concurrent chemoradiotherapy with intensity-modulated radiotherapy: A propensity score-matched, nationwide, population-based cohort study

Tsung-Ming Chen, Kuan‐Chou Lin, Kevin Sheng‐Po Yuan,

Radiotherapy and Oncology

2017

33

Survival prognostic factors for metachronous second primary head and neck squamous cell carcinoma

Jin‐Hua Chen, Yu‐Chun Yen, Tsung‐Ming Chen,

Cancer Medicine

2016

31

Risk of cardiotoxicity induced by adjuvant anthracycline-based chemotherapy and radiotherapy in young and old Asian women with breast cancer

Chih‐Hsin Lee, Jun-Fu Zhang, Kevin Sheng‐Po Yuan,

Strahlentherapie und Onkologie

2019

28

Page 1